Two Common Heart Drugs Show Promise in Reversing Fatty Liver Disease

1 min read
Source: Medical News Today
Two Common Heart Drugs Show Promise in Reversing Fatty Liver Disease
Photo: Medical News Today
TL;DR Summary

A study in animal models suggests that a combination of two common heart medications, pemafibrate and telmisartan, may reverse fat accumulation in the liver, offering a potential new treatment for early-stage fatty liver disease (MASLD). However, further clinical research is needed before these drugs can be recommended for human treatment.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

5 min

vs 6 min read

Condensed

96%

1,14250 words

Want the full story? Read the original article

Read on Medical News Today